The present invention is related to the preparation and pharmaceutical use ofnovelbenzamide derivatives as defined in the specification of formula (I) ashistone deacetylaseinhibitors (HDACI), their preparations and the methods of using thesecompounds ortheir pharmaceutically acceptable salt in the treatment of cell proliferativediseases, e.g.cancer and psoriasis.(see formula I)